ダウンロード数: 266
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 30_1167.pdf | 291.72 kB | Adobe PDF | 見る/開く |
| タイトル: | 転移を有する腎癌に対するCis-diamminedichloroplatinumを中心とした併用化学療法 |
| その他のタイトル: | Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs |
| 著者: | 奥村, 哲  西村, 泰司 吉田, 和弘 大原, 正雄 長谷川, 潤 平澤, 精一 原, 真 川村, 直樹 金森, 幸男 秋元, 成太 |
| 著者名の別形: | OKUMURA, Satoshi NISHIMURA, Taiji YOSHIDA, Kazuhiro OHHARA, Masao HASEGAWA, Jun HIRASAWA, Seiichi HARA, Makoto KAWAMURA, Naoki KANAMORI, Sachio AKIMOTO, Masao |
| キーワード: | Combination chemotherapy CDDP Metastatic renal cell carcinoma |
| 発行日: | Sep-1984 |
| 出版者: | 泌尿器科紀要刊行会 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 30 |
| 号: | 9 |
| 開始ページ: | 1167 |
| 終了ページ: | 1171 |
| 抄録: | Seven patients were entered in this study between November 1978 and February 1983. All patients had histologically proven renal cell carcinoma with widespread metastases. Patients ranged in age from 27 to 69 years, with an average of 54 years. All those studied had measurable radiological lesions of malignant disease. One patient was treated with only CDDP and the other 6 patients were treated with CDDP and other anti-cancer drugs (vinblastine, ifosfamide, bleomycin and/or adriamycin). Total doses of CDDP ranged from 20 to 250 mg, with an average of 99 mg. Four cases showed no change and 3 patients had progressive disease. Symptomatic improvement was obtained in only 2 patients. Management of metastatic renal cell carcinoma is discussed briefly. |
| URI: | http://hdl.handle.net/2433/118283 |
| PubMed ID: | 6084420 |
| 出現コレクション: | Vol.30 No.9 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。